Psychological stress and the subsequent appearance of new brain MRI lesions in MS

Neurology

Volumn 55, Issue 1, 2000, Pages 55-61

  Mohr, David C ^a,b   Goodkin, D E ^a   Bacchetti, P ^a   Boudewyn, A C ^a   Huang, L ^a   Marrietta, P ^a   Cheuk, W ^a   Dee, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFLICT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HUMAN; MALE; MENTAL STRESS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE;

EID: 0034641325     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.1.55     Document Type: Article

References (47)

1. Charcot JM. Lectures on diseases of the nervous system. London, UK: New Sydenham Society, 1877.
2. Goodin DS, Ebers GC, Johnson PCP, Rodriguez M, Sibley WA, Wolinsky JS. The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999;52:1737-1745.
3. Antonovsky A, Leibowitz U, Medalie JM, Smith A, Halpern L, Alter M. Reappraisal of possible etiologic factors in multiple sclerosis. Am J Public Health 1968;58:836-848.
4. Pratt RTC. An investigation of the psychiatric aspects of disseminated sclerosis. J Neurol Neurosurg Psychiatry 1951;14: 326-336.
5. Warren S, Greenhill S, Warren KG. Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship. J Chronic Dis 1982;35:821-831.
6. Grant I, Brown GW, Harris T, McDonald WI, Patterson T, Trimble MR. Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52:8-13.
7. Warren S, Warren KG, Cockerill R. Emotional stress and coping in multiple sclerosis and exacerbations. J Psychosom Res 1991;35:37-47.
8. Weingartner H, Eckardt M, Lister R. Affect specific retrieval from archival memory. In: Breznitz S, Zinder O, eds. Molecular biology of stress. Vol. 97. New York, NY: Alan R. Liss, 1989:277-284.
9. Dalos NP, Rabins PV, Brooks BR, O'Donnell P. Disease activity and emotional state in multiple sclerosis. Ann Neurol 1983;13:573-583.
10. Franklin GM, Nelson LM, Heaton RK, Burks JS, Thompson DS. Stress and its relationship to acute exacerbations in multiple sclerosis. J Neurol Rehabil 1988;2:7-11.
11. Sibley WA. Risk factors in multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW, eds. Multiple sclerosis: clinical and pathogenetic basis. London, UK: Chapman & Hall, 1997:141-148.
12. Nisipeanu P, Korczyn AD. Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993;43: 1311-1312.
13. Grossman RI. Magnetic resonance imaging: current status and strategies of improving multiple sclerosis clinical trial design. In: Goodkin DE, Rudick RA, eds. Multiple sclerosis: advances in clinical trial design, treatment and future perspectives. London, UK: Springer, 1996:161-186.
14. Goodkin DE, Rooney WD, Sloan R, et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998;51:1689-1697.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
16. Barkoff F, Tas MW, Frequin S. Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis. Neuroradiology 1994;36:382-387.
17. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17: 536-546.
18. Aneshensel CS, Frerichs RR, Clark VA, Yokopenic PA. Measuring depression in the community: a comparison of telephone and personal interviews. Public Opin Q 1982;46:110-121.
19. Debanne SM, Patterson MB, Dick R, Riedel TM, Schnell A, Rowland DY. Validation of a telephone cognitive assessment battery. J Am Geriatr Soc 1997;45:1352-1359.
20. Desmond DW, Tatemichi TK, Hanzawa L. The telephone interview for cognitive status (TICS): reliability and validity in a stroke sample. Int J Geriatr Psychiatry 1994;9:803-807.
21. Gallo JJ, Breitner JCS. Alzheimer's disease in the NAS-NRC registry of ageing twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med 1995;25:1211-1219.
22. Simon GE, Revicki D, Von Korff M. Telephone assessment of depression severity. J Psychiatr Res 1993;27:247-252.
23. Smith PM, Illig SB, Fielder RC, Hamilton BB, Ottenbacher KJ. Intermodal agreement of follow-up telephone functional assessment using the functional independence measure in patients with stroke. Arch Phys Med Rehabil 1996;77:431-435.
24. Tunstall N, Prince M, Mann A. Concurrent validity of a telephone-administered version of the Gospel Oak instrument (including the short-care). Int J Geriatr Psychiatry 1997;12: 1035-1038.
25. Wells KB, Burnam MA, Leake B, Robins LN. Agreement between face-to-face and telephone-administered versions of the depression section of the NIMH diagnostic interview schedule. J Psychiatr Res 1988;22:207-220.
26. Welsh KA, Breitner JCS, Magruder-Habib KM. Detection of dementia in elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6: 103-110.
27. Mohr DC, Dick LP, Russo D, et al. The psychosocial impact of multiple sclerosis: exploring the patient's perspective. Health Psychol 1999;18:376-382.
28. Pakenham KI. Adjustment to multiple sclerosis: application of a stress and coping model. Health Psychol 1999;18:383-392.
29. Holmes TH, Rahe RH. The Social Readjustment Scale. J Psychosom Med 1967;11:213-218.
30. Confavreux C, Hutchinson M, Hours MM, Cortinovix-Tournairire P, Moreau T, and the Pregnancy in MS Group. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998;339:285-291.
31. Turner RJ, Wheaton B. Checklist measurement of stressful life events. In: Cohen S, Kessler RC, Gordon LU, eds. Measuring stress: a guide for health and social sciences. New York, NY: Oxford University Press, 1995:29-51.
32. Kanner AD, Coyne JC, Schaefer C, Lazarus RS. Comparison of two modes of stress measurement: daily hassles and uplifts versus major life events. J Behav Med 1981;4:1-39.
33. McNair DM, Lorr M, Droppleman LF. Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service, 1981.
34. Hedeker D, Gibbons RD. A random-effects ordinal regression model for multilevel analysis. Biometrics 1994;50:933-944.
35. Lindsey JK, Lambert P. On the appropriateness of marginal models for repeated measurements in clinical trials. Stat Med 1998;17:447-469.
36. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis. Ann Neurol 1983;13:227-231.
37. Lublin FD, Reingold SC. Denning the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.
38. Correa SG, Rodriguez-Galâan MC, Rivero VE, Riera CM. Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats. Brain Behav Immun 1998; 12:134-148.
39. Whitacre CC, Dowdell K, Griffen AC. Neuroendocrine influences on experimental autoimmune encephalomyelitis. Ann NY Acad Sci 1998;840:705-716.
40. Kiecolt-Glaser JK. Stress, personal relationships, and immune function: health implications. Brain Behav Immun 1999;13:61-72.
41. Cohen S, Herbert TS. Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. In: Spence JT, Darley JM, Foss DJ, eds. Annual review of psychology. Vol. 47. Palo Alto, CA: Annual Reviews Inc., 1996:113-142.
42. Cohen S, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM. Social ties and susceptibility to the common cold. JAMA 1997; 277:1940-1944.
43. Rabin BS. Stress, immune function, and health: the connection. New York, NY: Wiley-Liss, 1999.
44. Zoukos Y, Kidd D, Woodroofe M, Kendall B, Thompson A, Cuzner M. Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis. Brain 1994;117:307-315.
45. Arnason BGW. Immunology and the autonomic nervous system. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Amsterdam, the Netherlands: Elsevier, 2000:75.
46. Karaszewski JW, Reder AT, Anlar B, Arnason BGW. Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis. J Neuroimmunol 1993;43:1-7.
47. Filippi M, Rocca MA, Martino G, Morsfield MA, Comi G. Magnetization transfer changes in normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814.